Tamoxifen in advanced breast cancer
- PMID: 365330
- DOI: 10.1016/s0305-7372(78)80017-6
Tamoxifen in advanced breast cancer
Similar articles
-
Endocrine treatment of advanced breast cancer.Recent Results Cancer Res. 1980;71:102-11. doi: 10.1007/978-3-642-81406-8_14. Recent Results Cancer Res. 1980. PMID: 6988909 Review. No abstract available.
-
Tamoxifen (antiestrogen) therapy in advanced breast cancer.Ann Intern Med. 1977 Dec;87(6):687-90. doi: 10.7326/0003-4819-87-6-687. Ann Intern Med. 1977. PMID: 931204
-
The place of tamoxifen in the treatment of breast cancer.Recent Results Cancer Res. 1980;71:212-4. doi: 10.1007/978-3-642-81406-8_32. Recent Results Cancer Res. 1980. PMID: 7367735 No abstract available.
-
Clinical experiences with tamoxifen for estrogen receptor blocking therapy in metastatic breast cancer.Prog Clin Biol Res. 1977;12:479-82. Prog Clin Biol Res. 1977. PMID: 918118 No abstract available.
-
Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.Breast Cancer Res Treat. 2003;80 Suppl 1:S19-26; discussion S27-8. doi: 10.1023/a:1025459232293. Breast Cancer Res Treat. 2003. PMID: 14535531 Review.
Cited by
-
The effects of estrogen on human breast carcinomas serially transplanted into nude mice.Jpn J Surg. 1989 Nov;19(6):718-25. doi: 10.1007/BF02471723. Jpn J Surg. 1989. PMID: 2607695
-
A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer.Cancer Chemother Pharmacol. 1985;14(3):272-3. doi: 10.1007/BF00258132. Cancer Chemother Pharmacol. 1985. PMID: 3888433 Clinical Trial.
-
Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione.Cancer Chemother Pharmacol. 1990;26(1):75-8. doi: 10.1007/BF02940300. Cancer Chemother Pharmacol. 1990. PMID: 2322991
-
New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefits.Pharmacoeconomics. 2000 Feb;17(2):121-32. doi: 10.2165/00019053-200017020-00002. Pharmacoeconomics. 2000. PMID: 10947336 Review.
-
Weekly low dose doxorubicin monotherapy in metastatic breast cancer resistant to previous hormonal and cytostatic treatment.Breast Cancer Res Treat. 1985;6(1):89-93. doi: 10.1007/BF01806014. Breast Cancer Res Treat. 1985. PMID: 4052636
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources